touchdown

Defense Wins Championships
Messages
4,824
Reaction score
3,613
Federal regulators say 52 million airbags pose safety risks to American drivers

 

touchdown

Defense Wins Championships
Messages
4,824
Reaction score
3,613
CBS

WFAA
 

touchdown

Defense Wins Championships
Messages
4,824
Reaction score
3,613
Psychedelic drug MDMA eases PTSD symptoms in a study that paves the way for possible US approval


The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday.

The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy.

“It’s the first innovation in PTSD treatment in more than two decades. And it’s significant because I think it will also open up other innovation,” said Amy Emerson, CEO of MAPS Public Benefit Corporation, the research sponsor.

Earlier this year, Australia became the first country to allow psychiatrists to prescribe MDMA and psilocybin, the psychoactive ingredient in psychedelic mushrooms. The drugs are gaining wider cultural acceptance in the U.S. in part because of efforts by the nonprofit advocacy group Multidisciplinary Association for Psychedelic Studies.
 
Top Bottom